Cleared Traditional

K181491 - Delta Dual Mobility System

K181491 is an FDA 510(k) clearance for Delta Dual Mobility System, manufactured by Lima Corporate S.P.A.. The device is a Class 2 Orthopedic device with product code LZO cleared through the Traditional 510(k) pathway after a 337-day FDA review.

K181491 · Lima Corporate S.P.A. · Orthopedic device
Download Printable Device Report (PDF)
Optimized for regulatory review, auditing and printing
May 2019
Decision
337d
Days
Class 2
Risk

K181491 is an FDA 510(k) clearance for the Delta Dual Mobility System. Classified as Prosthesis, Hip, Semi-constrained, Metal/ceramic/polymer, Cemented Or Non-porous, Uncemented (product code LZO), Class II - Special Controls.

Submitted by Lima Corporate S.P.A. (Villanova Di San Daniele Del Friuli, IT). The FDA issued a Cleared decision on May 9, 2019 after a review of 337 days - an unusually long review period, suggesting complex equivalence evaluation.

This device falls under the Orthopedic FDA review panel, regulated under 21 CFR 888.3353 - the FDA orthopedic device regulatory framework. The Traditional 510(k) pathway establishes clearance through substantial equivalence to a legally marketed predicate device, without requiring clinical trial data.

Device pattern: Standard predicate-based submission. Elevated predicate reliance profile. This clearance follows a standard predicate-based equivalence path within the Orthopedic review framework, consistent with the majority of Class II 510(k) submissions.

View all Lima Corporate S.P.A. devices

FDA 510(k) Submission Details - K181491

510(k) Number K181491 FDA.gov
FDA Decision Cleared Substantially Equivalent - Traditional 510(k) (SESE)
Date Received June 06, 2018
Decision Date May 09, 2019
Days to Decision 337 days
Submission Type Traditional
Review Panel Orthopedic (OR)
Summary Summary PDF
Third-party Review No - reviewed directly by FDA
Combination Product No
PCCP Authorized No
Regulatory Context
Review time vs. panel average
215d slower than avg
Panel avg: 122d · This submission: 337d
Pathway characteristics
Predicate-based equivalence. No clinical trials required.

LZO Device Classification - Class 2, Special Controls

Product Code LZO Prosthesis, Hip, Semi-constrained, Metal/ceramic/polymer, Cemented Or Non-porous, Uncemented
Device Class Class 2 - Special Controls
CFR Regulation 21 CFR 888.3353
What this classification means

Class II devices require demonstration of substantial equivalence to a legally marketed predicate device. This pathway does not require clinical trials - it relies on engineering equivalence and performance data. Most Orthopedic devices follow this clearance model.

Regulatory Consultant

Peoples & Associates Consulting, LLC
Stephen Peoples

The regulatory consultant manages the 510(k) submission process on behalf of the applicant - coordinating technical documentation, predicate strategy and FDA communications. Identifying the consultant behind a submission is a key signal for competitive regulatory intelligence.

Regulatory Peers - LZO Prosthesis, Hip, Semi-constrained, Metal/ceramic/polymer, Cemented Or Non-porous, Uncemented

All 508
Devices cleared under the same product code (LZO) and FDA review panel - the closest regulatory comparables to K181491.
Latitud Hip Replacement System
K183532 · Meril Healthcare Pvt. , Ltd. · Jul 2019
MasterLoc Extension
K191145 · Medacta International S.A. · May 2019
MobileLink Acetabular Cup System
K182321 · Waldemar Link GmbH & Co. KG · May 2019
Zimmer Biomet Ceramic Heads
K181171 · Zimmer, Inc. · Apr 2019
Libertas Acetabular Hooded Liner
K183365 · Maxx Orthopedics, Inc. · Feb 2019
Juveno Hip System Femoral Stem, b-ONE Primary Acetabular System Cups
K182705 · B-One Ortho, Corp. · Feb 2019